—

ADAR1 Capital Management, LLC

Q1 2026 13F Holdings

  • Location
    austin, TX
  • Num holdings

    310

  • Value ($000)

    $1,698,675

  • Date Filed
    05/18/2026
  • Form type
    13F-HR
  • CIK
    0001940272
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

ABIVAX SA

SPONSORED ADS
00370M103
$155.22M
9 %

1,394,019

P
PTGX

PROTAGONIST THERAPEUTICS INC

COM
74366E102
$104.78M
6 %

994,119

---

ROIVANT SCIENCES LTD

SHS
G76279101
$91.02M
5 %

3,285,906

I
IMVT

IMMUNOVANT INC

COM
45258J102
$66.55M
4 %

2,679,010

S
SPY

STATE STR SPDR S&P 500 ETF T

TR UNIT
78462F103
$49.39M
3 %

75,940

T
TERN

TERNS PHARMACEUTICALS INC

COM
880881107
$48.22M
3 %

914,699

C
CYTK

CYTOKINETICS INC

COM NEW
23282W605
$41.69M
3 %

632,556

C
CRNX

CRINETICS PHARMACEUTICALS IN

COM
22663K107
$41.38M
2 %

1,139,331

B
BOXX

EA SERIES TRUST

ALPHA ARCH 1-3
02072L565
$39.2M
2 %

337,125

D
DNLI

DENALI THERAPEUTICS INC

COM
24823R105
$35.93M
2 %

1,871,455

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 310